[{"NetIncomeLossConverted_1_Q2_USD":10558000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":233681000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":233348000.0,"RevenuesConverted_1_Q2_USD":687588000.0,"RevenuesConverted_2_Q2_USD":1507993000.0,"CommonStockSharesConverted_0_Q2_shares":229798823.0,"Assets_0_Q2_USD":9165134000.0,"EarningsPerShareBasic_1_Q2_USD":0.05,"StockholdersEquity_0_Q2_USD":-714867000.0,"EarningsPerShareDiluted_2_Q2_USD":0.6,"EarningsPerShareDiluted_1_Q2_USD":0.05,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":366888000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":229716000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":228457000.0,"NetIncomeLossConverted_2_Q2_USD":140488000.0,"CommonStockSharesOutstanding_0_Q2_shares":226802609.0,"EarningsPerShareBasic_2_Q2_USD":0.61,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]